Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Unique case of a <i>GLI1</i> amplified biphasic mesenchymal tumor of the orbit.

Orbit (Amsterdam, Netherlands)·2023

Same author

A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer.

British journal of cancer·2012

Same author

Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling.

Oncogene·2009

Same author

Problems in grading soft tissue sarcomas.

American journal of clinical pathology·2002

Same author

The role of megestrol acetate as an alternative to conventional hormone replacement therapy.

Climacteric : the journal of the International Menopause Society·2002

Same author

Management of soft-tissue sarcomas: an overview and update.

The Lancet. Oncology·2002

Search research articles

Related Experiment Video

Updated: Jul 4, 2026

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor

Published on: May 2, 2022

Gastrointestinal stromal tumours: an update.

N de S Somerhausen¹, C D Fletcher

¹Department of Pathology Brigham and Women's Hospital and Harvard Medical School 75 Francis Street Boston MA 02115 USA.

|June 4, 2008

Summary

Gastrointestinal stromal tumours (GISTs) concepts evolved over 30 years. Advances in diagnostics like immunohistochemistry and c-Kit mutation analysis clarified GIST origins and improved patient management.

Area of Science:

Gastroenterology
Oncology
Pathology

Background:

Gastrointestinal stromal tumours (GISTs) have presented diagnostic challenges for over three decades.
Controversies existed regarding their differentiation and behavior prediction.
Peritoneal GIST metastasis is notoriously difficult to manage.

Purpose of the Study:

To chronologically review the conceptual evolution of GISTs over 30 years.
To examine the impact of diagnostic advancements on GIST understanding.
To discuss how these advancements influence pathological assessment and clinical care.

Main Methods:

Review of scientific literature and diagnostic techniques over a 30-year period.
Analysis of the application of electron microscopy, immunohistochemistry, and DNA ploidy analysis.

More Related Videos

Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib

Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib

Published on: April 3, 2026

Related Experiment Videos

Last Updated: Jul 4, 2026

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor

Published on: May 2, 2022

Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib

Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib

Published on: April 3, 2026

Chronological examination of evolving GIST classification and understanding.

Main Results:

Identification of c-Kit mutations and KIT/CD117 expression as key diagnostic markers.
Reappraisal of GISTs as originating from interstitial cells of Cajal (with exceptions).
Improved definition of the pathological spectrum of GISTs.

Conclusions:

Diagnostic advancements have significantly refined the understanding of GISTs.
The identification of KIT/CD117 has been pivotal in GIST diagnosis and classification.
Enhanced diagnostic capabilities have led to improved pathological assessment and clinical management strategies for GISTs.